Institutional & Family Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $166 | Hold |
50
| – | – | ﹤0.01% | 730 |
|
|
2024
Q1 | $164 | Hold |
50
| – | – | ﹤0.01% | 715 |
|
|
2023
Q4 | $176 | Sell |
50
-1
| -2% | -$4 | ﹤0.01% | 694 |
|
|
2023
Q3 | $341 | Hold |
51
| – | – | ﹤0.01% | 682 |
|
|
2023
Q2 | $428 | Buy |
51
+27
| +113% | +$227 | ﹤0.01% | 696 |
|
|
2023
Q1 | $238 | Buy |
24
+1
| +4% | +$10 | ﹤0.01% | 707 |
|
|
2022
Q4 | $160 | Hold |
23
| – | – | ﹤0.01% | 700 |
|
|
2022
Q3 | $0 | Hold |
23
| – | – | ﹤0.01% | 696 |
|
|
2022
Q2 | $0 | Hold |
23
| – | – | ﹤0.01% | 716 |
|
|
2022
Q1 | $0 | Sell |
23
-1
| -4% | – | ﹤0.01% | 758 |
|
|
2021
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 791 |
|
|
2021
Q3 | $0 | Sell |
24
-17
| -41% | – | ﹤0.01% | 902 |
|
|
2021
Q2 | $0 | Buy |
+41
| New | – | ﹤0.01% | 941 |
|